Sole Source Award for Blood Culture Monitoring and Detection Analyzer and Reagents

The Department of Defense (DoD) has issued a contract notice for a blood culture monitoring and detection analyzer and reagents, with a sole source award to Biomerieux, Inc. The contract, worth a period of performance from October 2021 through September 2024, will be a firm fixed-price contract for the specified products at Tripler Army Medical Center in Hawaii. The DoD intends to use Biomerieux, Inc. due to the lack of alternative suppliers that can meet their requirements, as permitted by the Federal Acquisition Regulation (FAR) 13.501(a)(1)(ii).

Key Takeaways:

The DoD has issued a contract notice for a blood culture monitoring and detection analyzer and reagents, with a sole source award to Biomerieux, Inc.
The contract is a firm fixed-price contract worth a period of performance from October 2021 through September 2024.
The contract is for the specified products at Tripler Army Medical Center in Hawaii.
The DoD intends to use Biomerieux, Inc. due to the lack of alternative suppliers that can meet their requirements.
The Federal Acquisition Regulation (FAR) 13.501(a)(1)(ii) permits the DoD to award contracts when there is only one responsible source and no other suppliers or services will satisfy agency requirements.
The notice is not a request for competitive quotes, but responsible sources may submit a capability statement or quotation.
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents.

Statistics:

Contract duration: October 2021 through September 2024
Number of years: 3 years (base and two 1-year option periods)
NAICS code: 334510
Contracting office: Regional Health Contracting Office-Pacific
Contact person: Susan Mieko Afuso Fujita
Phone number: 808-438-5113
E-mail: susan.m.fujita.civ@mail.mil

Sources:

DoD, "Contract Opportunity for Blood Culture Monitoring and Detection Analyzer and Reagents" (August 7, 2021)